<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0864-2176</journal-id>
<journal-title><![CDATA[Revista Cubana de Oftalmología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Oftalmol]]></abbrev-journal-title>
<issn>0864-2176</issn>
<publisher>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0864-21762014000400006</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Perfil epidemiológico del donante y del receptor en trasplante de córnea en el Instituto Cubano de Oftalmología "Ramón Pando Ferrer"]]></article-title>
<article-title xml:lang="en"><![CDATA[Epidemiological profiles of the donor and the receiver in corneal transplantation at "Ramon Pando Ferrer" Cuban Institute of Ophthalmology]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Escalona Leyva]]></surname>
<given-names><![CDATA[Elizabeth Teresa]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez Parra]]></surname>
<given-names><![CDATA[Zaadia]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Castillo Pérez]]></surname>
<given-names><![CDATA[Alexeide]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jareño Ochoa]]></surname>
<given-names><![CDATA[Madelyn]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López Hernández]]></surname>
<given-names><![CDATA[Silvia Maria]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Instituto Cubano de Oftalmología Ramón Pando Ferrer  ]]></institution>
<addr-line><![CDATA[La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2014</year>
</pub-date>
<volume>27</volume>
<numero>4</numero>
<fpage>558</fpage>
<lpage>568</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0864-21762014000400006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0864-21762014000400006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0864-21762014000400006&amp;lng=en&amp;nrm=iso"></self-uri><kwd-group>
<kwd lng="es"><![CDATA[donante]]></kwd>
<kwd lng="es"><![CDATA[receptor]]></kwd>
<kwd lng="es"><![CDATA[trasplante de córnea]]></kwd>
<kwd lng="en"><![CDATA[donor]]></kwd>
<kwd lng="en"><![CDATA[receiver]]></kwd>
<kwd lng="en"><![CDATA[corneal transplantation]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <DIV class="Part"   >        <p align="right"   ><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif"><B>INVESTIGACI&Oacute;N</b></font></p >       <p align="right"   >&nbsp;</p >       <p align="left"   ><font face="Verdana, Arial, Helvetica, sans-serif" size="4"><b>Perfil epidemiol&oacute;gico      del donante y del receptor en trasplante de c&oacute;rnea en el Instituto      Cubano de Oftalmolog&iacute;a &quot;Ram&oacute;n Pando Ferrer&quot;</b></font></p >       <p align="left"   >&nbsp;</p >       <p align="left"   ><font face="Verdana, Arial, Helvetica, sans-serif" size="4"><b><font size="+1" color="#000000"><font size="+1" color="#000000"><font color="#212121" face="Verdana, Arial, Helvetica, sans-serif" size="3">Epidemiological      profiles of the donor and the receiver in corneal transplantation at &quot;Ramon      Pando Ferrer&quot; Cuban Institute of Ophthalmology</font></font></font></b></font></p >       <p align="left"   >&nbsp;</p >       <p align="left"   >&nbsp;</p >   <FONT size="+1" color="#000000"><B></B>        <p   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Dra. Elizabeth      Teresa Escalona Leyva, Dra. Zaadia P&eacute;rez Parra, Dra. Alexeide Castillo      P&eacute;rez, Dra. Madelyn Jare&ntilde;o Ochoa, Dra. Silvia Maria L&oacute;pez      Hern&aacute;ndez </b> </font></p >       <p   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Instituto Cubano      de Oftalmolog&iacute;a &quot;Ram&oacute;n Pando Ferrer&quot;. La Habana, Cuba.      </font></p >       ]]></body>
<body><![CDATA[<p   >&nbsp;</p >       <p   >&nbsp;</p >   </font>   <hr>   <FONT size="+1" color="#000000">     <br>   <font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>RESUMEN </B></font>        <p   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>Objetivos: </B>describir      el perfil epidemiol&oacute;gico de los donantes y receptores de c&oacute;rneas      en el Banco de Ojos del Instituto Cubano de Oftalmolog&iacute;a &quot;Ram&oacute;n      Pando Ferrer&quot;. <B>    <br>     M&eacute;todos:</B> se realiz&oacute; un estudio descriptivo y transversal.      La muestra se conform&oacute; con 590 donantes y 270 receptores registrados      en las bases de datos del Banco de Ojos del Instituto Cubano de Oftalmolog&iacute;a      &quot;Ram&oacute;n Pando Ferrer&quot; durante el a&ntilde;o 2012. Las variables      estudiadas fueron la edad y el sexo del donante y del receptor, la causa de      muerte y el centro donador, la indicaci&oacute;n de cirug&iacute;a y la t&eacute;cnica      quir&uacute;rgica realizada. <B>    <br>     Resultados:</B> en los donantes de c&oacute;rnea, el 60,67 % fueron del sexo      masculino y el 51,18 % ten&iacute;an entre 51 y 70 a&ntilde;os. El 67,9 %      proced&iacute;a de los hospitales de La Habana. Las causas de muerte m&aacute;s      frecuentes fueron la enfermedad cardiovascular (29 %) y las cerebrovasculares      (24,7 %). En los receptores, el 50,3 % pertenec&iacute;a al sexo masculino,      el 44,4 % ten&iacute;a entre 51 y 70 a&ntilde;os. Las principales indicaciones      con fines &oacute;pticos fueron la queratopat&iacute;a bullosa pseudof&aacute;quica      (37 %), el rechazo al trasplante (12,2 %) y los leucomas corneales (10,7 %).      Predominaron la queratoplastia penetrante (44,8 %) y la endoqueratoplastia      (1,4 %). <B>    <br>     Conclusiones: </B>la enfermedad cardiovascular como principal causa de muerte      y el sexo masculino entre 50 y 70 a&ntilde;os de edad caracterizaron al donante      corneal. Las edades entre 50 y 70 a&ntilde;os, el sexo masculino, la queratopat&iacute;a      bullosa y la queratoplastia penetrante como t&eacute;cnica quir&uacute;rgica      correspondieron al receptor de c&oacute;rnea. </font></p >       <p   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>Palabras clave:      </B>donante, receptor, trasplante de c&oacute;rnea. </font></p >   </font>   <hr>   <FONT size="+1" color="#000000">     <br>   <font color="#212121" face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>ABSTRACT</B></font>        <p   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><b>Objective:</b>      to identify the epidemiological profiles of donors and receptors in corneal      transplantation at the eye bank of &quot;Ramon Pando Ferrer&quot; Cuban Institute      of Ophthalmology in 2012.    ]]></body>
<body><![CDATA[<br>     <b>Methods:</b> a descriptive cross-sectional study of the total number of      donors registered in the eye bank and the transplanted patients during 2012      at &quot;Ramon Pando Ferrer&quot; Cuban Institute of Ophthalmology. Age, sex,      donor center and cause of death were the considered data for donors whereas      age, sex, diagnosis and surgical technique were those of the receiver. All      this information was collected from the eye bank's databases.    <br>     <b>Results:</b> five hundred and ninety donors were received (1 175 corneas)      where 51-70 age group and males predominated. The main cause of death was      cardiovascular disease (171) followed by cerebrovascular ones (146). Two hundred      and seventy corneal transplantations were analyzed with 51 to 70 years-old      patients and males prevailing. Pseudophakic keratopathy bulosa (100), graft      rejection (33) and corneal leukomas (29) were the main indications and the      most used surgical techniques were penetrating keratoplasty (183) and endokeratoplasty      (72).    <br>     <b>Conclusions:</b> the most common cause of death for donors was cardiovascular      disease; 51-70 age group and males prevailed. Keratoplasty bulosa was the      main prescription and penetrating keratoplasty was the most common surgical      technique.</font></p >   </font>        <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B>Key words:      </B>donor, receiver, corneal transplantation.</font></p>   <FONT size="+1" color="#000000"></font>    <hr>   <FONT size="+1" color="#000000">       <p   >&nbsp;</p >   <FONT color="#212121"></font></font></DIV >     <p><FONT size="+1" color="#000000"><FONT color="#212121"> </font></font></p> <FONT size="+1" color="#000000"><FONT color="#212121">      <DIV class="Part"   >        <p   align="justify" ><font color="#000000" face="Verdana, Arial, Helvetica, sans-serif" size="2"><B><font size="3">INTRODUCCI&Oacute;N      </font> </b></font></p >       <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">La queratoplastia,      como tambi&eacute;n se denomina al trasplante de c&oacute;rnea, es una de      las t&eacute;cnicas quir&uacute;rgicas m&aacute;s antiguas de la Oftalmolog&iacute;a.      Consiste </font><font size="+1" color="#000000"><font color="#212121"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">b&aacute;sicamente</font></font></font>      <font face="Verdana, Arial, Helvetica, sans-serif" size="2">en la sustituci&oacute;n      de una c&oacute;rnea enferma por otra sana.<Sup>1,2 </Sup> A pesar de sus      muchas virtudes, sigue siendo una opci&oacute;n terap&eacute;utica compleja      de resultados en ocasiones impredecibles, lo que nos obliga a prestarle atenci&oacute;n      prioritaria en cuanto a investigaci&oacute;n y empleo de recursos. La obtenci&oacute;n      de tejidos oculares se realiza a partir de cad&aacute;veres y donantes en      estado de muerte cerebral. Una vez obtenido el tejido donante se traslada      a los Bancos de Ojos, que son instituciones con funciones establecidas, encargadas      de la obtenci&oacute;n de globos oculares para su an&aacute;lisis, procesamiento,      conservaci&oacute;n y distribuci&oacute;n de tejidos oculares para ser utilizados      en cirug&iacute;a de trasplante, cumpliendo con normas internacionales donde      rigen los aspectos &eacute;ticos. </font></p>   <FONT color="#000000"><FONT size="+1"><FONT size="+1">        <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">La demanda de c&oacute;rneas      para trasplantes en todo el mundo es alta y no existe un equilibrio entre      la donaci&oacute;n y los pacientes que requieren esta cirug&iacute;a, por      lo que es limitado este servicio en muchos pa&iacute;ses. Es por esto que      las asociaciones internacionales est&aacute;n </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">trabajando</font></font></font></font></font></font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">      incansablemente en este importante rengl&oacute;n para satisfacer las necesidades      de estas personas. En datos recientes publicados por la Asociaci&oacute;n      Americana y la Europea de Banco de Ojos se da a conocer que en los Estados      Unidos 85 Bancos de Ojos reportaron 110 600 donaciones en 2010. Un total de      59 271 botones corneales fueron suministrados y </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">se      realizaron </font></font></font></font></font></font> <font face="Verdana, Arial, Helvetica, sans-serif" size="2">42      642 trasplantes corneales. En Europa, aproximadamente 20 000 procedimientos      de trasplante corneal son realizados cada a&ntilde;o y se obtienen 35 000      c&oacute;rneas. En la India, el pa&iacute;s con la poblaci&oacute;n m&aacute;s      grande de ceguera corneal del mundo, hay una necesidad para aproximadamente      100 000 c&oacute;rneas anualmente; pero hay solo alrededor de 17 000 ojos      obtenidos en un a&ntilde;o, de los cuales solo cerca de 50 a 60 % es utilizado.      Se reporta que en Sorocaba, Brasil, donde se encuentra uno de los Bancos de      Ojos m&aacute;s grandes y eficientes del mundo, se procesan m&aacute;s de      300 c&oacute;rneas cada mes.<Sup>3 </Sup>El Banco de Ojos del Instituto Cubano      de Oftalmolog&iacute;a en Cuba es el banco rector de la actividad de donaci&oacute;n      y trasplante corneal a nivel nacional; recibe los donantes provenientes de      todas las provincias y, a la vez, distribuye las c&oacute;rneas procesadas      y conservadas a todos los centros de trasplante a lo largo de todo el pa&iacute;s.      Anualmente se reciben alrededor de 600 donantes (1 200 c&oacute;rneas). </font></p >   <FONT size="+1"><FONT size="+1">        ]]></body>
<body><![CDATA[<p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Los Bancos de Ojos      mantienen una estrecha relaci&oacute;n con un servicio de coordinaci&oacute;n      de trasplante para la obtenci&oacute;n y distribuci&oacute;n de tejidos oculares.      El desarrollo en el trabajo de los Bancos de Ojos tiene una influencia directa      en la calidad final de la c&oacute;rnea donada y consecuentemente en el resultado      quir&uacute;rgico posterior al trasplante; de aqu&iacute; la importancia de      realizar estudios en esta &aacute;rea para mejorar la calidad de los tejidos      distribuidos, determinando problemas directamente relacionados en las diversas      etapas de la donaci&oacute;n de c&oacute;rneas.<Sup>4 </Sup></font></p >   <FONT size="+1">        <p   align="justify" ><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Las enfermedades      de la c&oacute;rnea se encuentran entre las causas principales de ceguera      y discapacidad visual en los pa&iacute;ses en desarrollo. Aunque las afecciones      que conllevan un trasplante de c&oacute;rnea son variadas, las indicaciones      tienen una tendencia al cambio en diferentes pa&iacute;ses del mundo. Las      variadas t&eacute;cnicas quir&uacute;rgicas en trasplante de c&oacute;rnea      est&aacute;n en relaci&oacute;n directa con el diagn&oacute;stico preoperatorio      de cada paciente y su adecuada selecci&oacute;n es importante para el &eacute;xito      del trasplante. </font></p >   <FONT size="+1">        <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Cuba cuenta con una      Coordinaci&oacute;n Nacional de Trasplante de C&oacute;rnea desde el a&ntilde;o      2001, encargada de la coordinaci&oacute;n del Programa de Donaci&oacute;n      y Trasplante en el pa&iacute;s, y que ha garantizado la actividad organizativa      del proceso de donaci&oacute;n-trasplante con el apoyo incondicional del Estado,      lo que permite que existan condiciones objetivas favorables para mejorar sistem&aacute;ticamente      la obtenci&oacute;n de &oacute;rganos y tejidos, en consonancia con las crecientes      demandas existentes. En trasplante de c&oacute;rnea en el pa&iacute;s hemos      avanzado no solo en la cantidad sino tambi&eacute;n en la calidad, gracias      al mejoramiento e introducci&oacute;n de nuevas t&eacute;cnicas quir&uacute;rgicas      y a los procedimientos de diagn&oacute;stico, seguimiento y tratamiento. Contamos      con un Programa Nacional de Trasplante de C&oacute;rnea que tiene como funci&oacute;n      fundamental la organizaci&oacute;n de la actividad de donaci&oacute;n y trasplante,      as&iacute; como establecer las normas y regulaciones necesarias para el logro      de resultados satisfactorios en este campo. </font></p >       <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">El progreso en Banco      de Ojos tanto en organizaci&oacute;n como en recursos humanos materiales y      nivel cient&iacute;fico tambi&eacute;n ha permitido un importante avance,      y ha logrado el mejoramiento en la obtenci&oacute;n, procesamiento, conservaci&oacute;n      y distribuci&oacute;n de los tejidos oculares, lo que ha llevado a un aumento      en la calidad de los tejidos procesados y a la mejor supervivencia de los      trasplantes con la mejor&iacute;a de la calidad visual de nuestros pacientes.      </font></p >       <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">En este estudio consideramos      importante identificar en Cuba las caracter&iacute;sticas tanto del donante      como de los receptores que se registran en el Banco de Ojos, lo que nos ayudar&aacute;      al conocimiento de la procuraci&oacute;n de donantes en el pa&iacute;s y las      tendencias actuales en indicaciones y t&eacute;cnicas quir&uacute;rgicas en      trasplante de c&oacute;rnea, lo cual pudiera &#151;a trav&eacute;s de sus      resultados</font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&#151;</font></font></font></font></font></font></font></font></font></font>      <font face="Verdana, Arial, Helvetica, sans-serif" size="2"> mejorar nuestros      protocolos de actuaci&oacute;n en la obtenci&oacute;n, selecci&oacute;n y      criterios de inclusi&oacute;n de donantes y receptores para trasplantes de      c&oacute;rnea. </font></p >   </font></font></font></font></font></font></font></DIV > <FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   >        <p   align="justify" >&nbsp;</p >       <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B><font size="3">M&Eacute;TODOS      </font> </b></font></p >       <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Se realiz&oacute;      un estudio descriptivo y transversal de los donantes y receptores de c&oacute;rnea      registrados en el Banco de Ojos del Instituto Cubano de Oftalmolog&iacute;a      &quot;Ram&oacute;n Pando Ferrer&quot; (ICO), en La Habana, Cuba, en el periodo      comprendido de enero a diciembre de 2012. </font></p >       <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Se incluyeron en      el estudio todos los donantes recibidos en el Banco (590) y de los receptores      solamente los que se realizaron en el ICO </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&quot;Ram&oacute;n      Pando Ferrer&quot; </font></font></font></font></font></font></font></font></font></font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">      durante este periodo (270). </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">La      recolecci&oacute;n de la informaci&oacute;n se obtuvo de la base de datos      del Registro de donantes y receptores del Banco de Ojos y se tuvieron en cuenta      las siguientes variables: edad, sexo, procedencia y causa de muerte del donante      y la edad, sexo, finalidad del trasplante y el tipo de cirug&iacute;a realizado      en el receptor. </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Los      resultados se resumieron en tablas y gr&aacute;ficos, expresados en frecuencias      absolutas y relativas. Durante este estudio se respetaron los principios &eacute;ticos      que rigen los programas de donaci&oacute;n y trasplante en el pa&iacute;s.      </font></p >       ]]></body>
<body><![CDATA[<p   align="justify" >&nbsp;</p > </DIV >     <DIV class="Part"   >        <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B><font size="3">RESULTADOS      </font></b></font></p >       <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">En la <a href="#t1">tabla      1</a> se muestra que de los 590 donantes que se recibieron en el Banco de      Ojos predomin&oacute; el sexo masculino con 60,67 % y la edad m&aacute;s frecuente      estuvo entre 51 y 70 a&ntilde;os en el 51,18 % seguidos de los mayores de      71 a&ntilde;os (31,18 %). </font></p >       <p   align="justify" >&nbsp;</p > </DIV > </font></font></font></font></font></font></font></font></font>     <blockquote><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">       <DIV class="Part"   >         <div align="center">            <p><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><img src="/img/revistas/oft/v27n4/t0106414.gif" width="498" height="196"><a name="t1"></a></font></font></font></font></font></font></font></font></font></p>           <p>&nbsp;</p>     </div>   </DIV >   </font></font></font></font></font></font></font></font></font></blockquote> <FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      ]]></body>
<body><![CDATA[<DIV class="Part"   >        <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Los donantes eran      obtenidos desde todos los hospitales del pa&iacute;s que est&aacute;n acreditados      para esta actividad. Seg&uacute;n la procedencia de los donantes, los centros      que mayor n&uacute;mero de donantes aportaron fueron los hospitales de la      Provincia La Habana, con el 67,9 % (<a href="#t2">tabla 2</a>). </font></p >       <p   align="justify" >&nbsp;</p > </DIV > </font></font></font></font></font></font></font></font></font>     <blockquote><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">       <DIV class="Part"   >         <div align="center">            <p><img src="/img/revistas/oft/v27n4/t0206414.gif" width="410" height="348"><a name="t2"></a></p>           <p>&nbsp;</p>     </div>   </DIV >   </font></font></font></font></font></font></font></font></font></blockquote> <FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   >        <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">En la <a href="#t3">tabla      3</a> se observa que de los 590 donantes las causas de muerte m&aacute;s frecuentes      fueron las enfermedades del coraz&oacute;n en 171 (29 %), las enfermedades      cerebrovasculares en 146 (24,7 %) y las enfermedades respiratorias en 97 (16,4      %). </font></p >       ]]></body>
<body><![CDATA[<p   align="justify" >&nbsp;</p > </DIV > </font></font></font></font></font></font></font></font></font>     <blockquote><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">       <DIV class="Part"   >         <div align="center">            <p><img src="/img/revistas/oft/v27n4/t0306414.gif" width="558" height="395"><a name="t3"></a></p>           <p>&nbsp;</p>     </div>   </DIV >   </font></font></font></font></font></font></font></font></font></blockquote> <FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   >        <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Del total de donantes,      se utilizaron en el Instituto Cubano de Oftalmolog&iacute;a </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">&quot;Ram&oacute;n      Pando Ferrer&quot; </font></font></font></font></font></font></font></font></font></font><font face="Verdana, Arial, Helvetica, sans-serif" size="2">      270 c&oacute;rneas para trasplante y del estudio de esta muestra en relaci&oacute;n      con los receptores observamos que predomin&oacute; el sexo masculino en 136      casos (50,3 %) y la edad m&aacute;s frecuente estuvo representada con 120      casos (44,4 %) entre 51 y 70 a&ntilde;os (<a href="#t4">tabla 4</a>). </font></p >       <p   align="justify" >&nbsp;</p > </DIV > </font></font></font></font></font></font></font></font></font>     <blockquote><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">       ]]></body>
<body><![CDATA[<DIV class="Part"   >         <div align="center">            <p><img src="/img/revistas/oft/v27n4/t0406414.gif" width="451" height="201"><a name="t4"></a></p>           <p>&nbsp;</p>     </div>   </DIV >   </font></font></font></font></font></font></font></font></font></blockquote> <FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   >        <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Como se muestra en      la <a href="#t5">tabla 5</a>, la mayor&iacute;a de los trasplantes realizados      tuvieron finalidad &oacute;ptica, con 207 casos (76,6 %). La finalidad terap&eacute;utica      y/o tect&oacute;nica estuvo representada en 63 casos de trasplante (23,3 %).      Las indicaciones preoperatorias de los trasplantes de c&oacute;rnea con finalidad      &oacute;ptica m&aacute;s frecuentes fueron la queratopat&iacute;a bullosa      af&aacute;quica o pseudof&aacute;quica, con 100 casos (37 %), el rechazo al      trasplante, con 33 casos (12,2 %) y el leucoma corneal en 29 casos (10,7 %).      El descemetocele y la perforaci&oacute;n corneal fueron las principales causas      de queratoplastia con fines terap&eacute;uticos en 39 pacientes (14,4 %).      </font></p >       <p   align="justify" >&nbsp;</p > </DIV > </font></font></font></font></font></font></font></font></font>     <blockquote><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">       <DIV class="Part"   >         <div align="center">            ]]></body>
<body><![CDATA[<p><img src="/img/revistas/oft/v27n4/t0506414.gif" width="539" height="352"><a name="t5"></a></p>           <p>&nbsp;</p>     </div>   </DIV >   </font></font></font></font></font></font></font></font></font></blockquote> <FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   >        <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">La <a href="#t6">tabla      6</a> refleja que la t&eacute;cnica quir&uacute;rgica que predomin&oacute;      fue la queratoplastia penetrante (QPP) en 183 pacientes en sus diferentes      t&eacute;cnicas: QPP (44,8 %), triples procedimientos (12,9 %) y procederes      combinados (10 %). Le sigui&oacute; en orden de frecuencia la endoqueratoplastia      en 72 casos (26,6 %).</font></p >       <p   align="justify" >&nbsp;</p > </DIV > </font></font></font></font></font></font></font></font></font>     <blockquote><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">       <DIV class="Part"   >         <div align="center">            <p><img src="/img/revistas/oft/v27n4/t0606414.gif" width="396" height="253"><a name="t6"></a></p>           <p>&nbsp;</p>     </div>   </DIV >   </font></font></font></font></font></font></font></font></font></blockquote> <FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">     ]]></body>
<body><![CDATA[<DIV class="Part"   >        <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B><font size="3">DISCUSI&Oacute;N      </font> </b></font></p >       <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Entre las funciones      que de forma obligatoria se desarrollan en los Bancos de Ojos est&aacute;      realizar un control y registro casu&iacute;stico de los datos generales del      donante, guardar adecuada y &eacute;ticamente todo lo concerniente a la causa      de muerte, enfermedades acompa&ntilde;antes, pruebas serol&oacute;gicas realizadas      de hepatitis B, C, HIV y rechazo de su donaci&oacute;n si la hubiera. Es tambi&eacute;n      responsable de realizar el registro de los datos generales de los receptores      y sus indicaciones quir&uacute;rgicas para as&iacute; proceder a la distribuci&oacute;n      adecuada de los tejidos donantes.<Sup>5,6 </Sup></font></p >       <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">El proceso de      donaci&oacute;n-trasplante, as&iacute; como el trabajo de los Bancos de Ojos,      est&aacute; sujeto a normas dictadas por las experiencias acumuladas en el      curso de varias d&eacute;cadas, desde la fundaci&oacute;n del primer Banco      de Ojos en 1948 por <i>Patton</i>, en New York, y referenciadas por diversas      organizaciones como la Asociaci&oacute;n Panamericana de Banco de Ojos (APABO).<Sup>7      </Sup></font></p>   <FONT size="+1"><FONT size="+1"><FONT size="+1">        <p   align="justify" ><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Se acepta que el      resultado final en el proceso donaci&oacute;n-trasplante depende de m&uacute;ltiples      factores que van desde las caracter&iacute;sticas epidemiol&oacute;gicas,      demogr&aacute;ficas del donante y receptor hasta los procederes que se inician      en la obtenci&oacute;n hasta la realizaci&oacute;n del trasplante, transitando      por una serie de eventos que, de no cumplir con las normas establecidas, ser&iacute;a      imposible un resultado final exitoso. </font></p >   <FONT size="+1">        <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">La selecci&oacute;n      del donante de tejido corneal tiene como objetivos evitar la transmisi&oacute;n      de enfermedades al receptor y asegurar la calidad del tejido a implantar.      Seg&uacute;n las normas de la Asociaci&oacute;n Panamericana de Banco de Ojos      (APABO) y la Asociaci&oacute;n Americana de Banco de Ojos (EBAA), el protocolo      de selecci&oacute;n del donante incluye el criterio de evaluaci&oacute;n desde      la entrevista con la familia del donante, el an&aacute;lisis de la historia      cl&iacute;nica para determinar antecedentes y la causa de muerte hasta la      evaluaci&oacute;n del cuerpo del donante y, por tanto, del tejido donado.<Sup>8      </Sup></font></p >   <FONT size="+1">        <p   align="justify" ><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Los criterios de      evaluaci&oacute;n de las c&oacute;rneas y el cumplimiento de los procedimientos      son indispensables y es responsabilidad de los Bancos de tejidos oculares.      Con este enfoque algunos datos sobre la c&oacute;rnea </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">donante</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font size="2" face="Verdana, Arial, Helvetica, sans-serif">,      as&iacute; como la edad y la causa de muerte, son pautas de dudas sobre la      calidad de la c&oacute;rnea.<Sup>9 </Sup></font></p >   <FONT size="+1"><FONT size="+1">        <p   align="justify" ><font size="2" face="Verdana, Arial, Helvetica, sans-serif">En relaci&oacute;n      con la edad aceptada por los Bancos de Ojos para el donante hay diversidad      de opiniones y en la mayor&iacute;a de los centros no se establece un valor      limitante.<Sup>10</Sup> La gran curvatura y di&aacute;metro estrecho en menores      de 2 a&ntilde;os hacen que por debajo de esta edad no se consideren buenos      donantes. </font></p >   <FONT size="+1"><FONT size="+1"><FONT size="+1">        <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">De manera general,      est&aacute; demostrado que para la donaci&oacute;n de la c&oacute;rnea no      existen l&iacute;mites m&aacute;ximos de edad porque no siempre existe una      relaci&oacute;n directa entre la calidad del tejido corneal y la edad del      donante. Es m&aacute;s importante la densidad y la morfolog&iacute;a celular      del endotelio; una c&oacute;rnea con estos factores normales es &oacute;ptima      para trasplante, independientemente de la edad.<Sup>11 </Sup>Por tanto, la      opini&oacute;n generalizada es que la edad de la c&oacute;rnea donante no      es un factor determinante en la calidad de la c&oacute;rnea,y se puede evaluar      su viabilidad en Banco de Ojos mediante la biomicroscop&iacute;a con l&aacute;mpara      de hendidura, microscop&iacute;a especular, paquimetr&iacute;a y m&aacute;s      recientemente la microscopia confocal.<Sup>12-14 </Sup></font></p >   <FONT size="+1"><FONT size="+1"><FONT size="+1">        <p   align="justify" ><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Para la selecci&oacute;n      del donante de c&oacute;rnea es prioritario determinar la causa de muerte,      ya que de eso depende que sea aceptada como donante seg&uacute;n las regulaciones      establecidas internacionalmente en las indicaciones relativas y absolutas.      Existen Bancos de Ojos que aceptan algunas causas de muerte como indicaci&oacute;n      relativa y para otros la hacen absoluta; esto es a criterio de cada Banco      e incluso del pa&iacute;s en cuesti&oacute;n. </font></p >   <FONT size="+1">        ]]></body>
<body><![CDATA[<p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">En los 590 donantes      que se recibieron, las principales causas de muerte fueron las enfermedades      del coraz&oacute;n, las cerebrovasculares y las enfermedades respiratorias.      En Cuba, seg&uacute;n el anuario estad&iacute;stico del 2012, se reportan      como principales causas de muerte las enfermedades del coraz&oacute;n, lo      cual coincide con nuestra casu&iacute;stica. Le siguen en orden de frecuencia      los tumores malignos, las enfermedades cerebrovasculares, las enfermedades      respiratorias y los accidentes.<Sup>15 </Sup></font></p >   <FONT size="+1">        <p   align="justify" ><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Cuba cuenta con un      servicio de coordinaci&oacute;n de trasplante en cada hospital acreditado      para desarrollar esta actividad, y ellos son los encargados de la evaluaci&oacute;n      y selecci&oacute;n del donante, as&iacute; como la obtenci&oacute;n de los      globos oculares. Se ha creado un mecanismo organizativo que ha permitido la      reducci&oacute;n de los intervalos de tiempo en cada etapa del proceso hasta      la llegada del tejido al Banco de Ojos. En este estudio encontramos que la      mayor&iacute;a de las provincias del pa&iacute;s enviaron tejidos al Banco      de Ojos, sin embrago, fue la provincia de La Habana la que mayor donantes      aport&oacute; y esto est&aacute; relacionado con la cercan&iacute;a geogr&aacute;fica      con el Banco de Ojos, la cantidad de Hospitales que existen en la capital      as&iacute; como con la gesti&oacute;n en la coordinaci&oacute;n hospitalaria      en la obtenci&oacute;n de los donantes. </font></p >   <FONT size="+1">        <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">El Banco de Ojos      realiza dentro de sus funciones el registro de los receptores a trav&eacute;s      de las listas de espera y de los operados de trasplante de c&oacute;rnea en      todo el pa&iacute;s. En este estudio, predominaron los pacientes mayores de      50 a&ntilde;os. este dato coincide con la principal indicaci&oacute;n de trasplante      de c&oacute;rnea en nuestra serie, que fue la queratopat&iacute;a bullosa      af&aacute;quica y pseudof&aacute;quica. Como resultado de la evoluci&oacute;n      natural de la catarata, es m&aacute;s frecuente la presencia de catarata que      requiere intervenci&oacute;n quir&uacute;rgica en estos grupos de edades,      y la queratopat&iacute;a bullosa es una de las complicaciones posquir&uacute;rgicas      m&aacute;s frecuentes. </font></p >       <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">En nuestro medio,      as&iacute; como en el resto del mundo, la realizaci&oacute;n de los trasplantes      con finalidad &oacute;ptica son los que predominan. El trasplante terap&eacute;utico      y/o tect&oacute;nico se realiz&oacute; en un porcentaje elevado, lo que est&aacute;      relacionado con que el Instituto Cubano de Oftalmolog&iacute;a es un centro      de referencia nacional y se reciben los pacientes remitidos de las distintas      provincias del pa&iacute;s. </font></p >       <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">En Cuba, en un estudio      publicado en el 2009, de una serie de 300 trasplantes se describe que la mayor&iacute;a      de los trasplantes realizados tuvieron finalidad &oacute;ptica, con 232 casos      (77,3 %), la finalidad terap&eacute;utica y/o tect&oacute;nica estuvo presente      en 65 casos de trasplante (21,7 %). En este mismo estudio se concluy&oacute;      que las indicaciones preoperatorias de los trasplantes de c&oacute;rnea m&aacute;s      frecuentes fueron la queratopat&iacute;a bullosa af&aacute;quica o pseudof&aacute;quica      seguido por el leucoma corneal y la perforaci&oacute;n corneal y descemetocele.<Sup>16      </Sup></font></p >   <FONT size="+1">        <p   align="justify" ><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Otras estad&iacute;sticas      mundiales se refieren a estudios con diferentes indicaciones, y se reporta      que en Nueva Zelanda la primera indicaci&oacute;n de trasplante fue el queratocono,      seguido del fallo del trasplante.<Sup>17</Sup> En la India tambi&eacute;n      reportaron el queratocono como primera indicaci&oacute;n y en Grecia se report&oacute;      una incidencia de edema corneal y de queratocono.<Sup>18 </Sup></font></p >   <FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        <p   align="justify" ><font size="2" face="Verdana, Arial, Helvetica, sans-serif">A pesar de la aparici&oacute;n      de t&eacute;cnicas quir&uacute;rgicas de catarata novedosas y cada vez m&aacute;s      sofisticadas, a&uacute;n la queratopat&iacute;a bullosa contin&uacute;a siendo      la principal causa de trasplante corneal, lo que responde en parte al criterio      de selecci&oacute;n de la t&eacute;cnica adecuada y personalizada para realizar      la cirug&iacute;a seg&uacute;n el estado corneal que tiene el paciente, as&iacute;      como al per&iacute;odo de aprendizaje de estas t&eacute;cnicas. Estos factores      son, a nuestro entender, lo que ha propiciado en la actualidad que contin&uacute;e      apareciendo esta complicaci&oacute;n. </font></p >   <FONT size="+1">        <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Est&aacute;n descritas      una variedad de t&eacute;cnicas quir&uacute;rgicas en trasplante de c&oacute;rnea      que van desde las queratoplastias penetrantes hasta las lamelares anteriores      y posteriores. A pesar de que las t&eacute;cnicas m&aacute;s novedosas de      trasplantes lamelares han ganado auge en los &uacute;ltimos a&ntilde;os, sigue      siendo la queratoplastia penetrante la m&aacute;s frecuentemente realizada      en el mundo. No obstante, en algunos estudios &#151;como el realizado en Inglaterra      por <i>Darren SJ Ting</i> y otros, durante 10 a&ntilde;os encontraron que      las queratoplastias lamelares anteriores y endoqueratoplastia mostraron una      tendencia a su elecci&oacute;n en afecciones anteriores y posteriores de la      c&oacute;rnea.<Sup>19 </Sup></font></p >   <FONT size="+1">        <p   align="justify" ><font size="2" face="Verdana, Arial, Helvetica, sans-serif">La queratoplastia      penetrante ha sido el procedimiento quir&uacute;rgico por excelencia para      el tratamiento de las opacidades corneales. Como en otros estudios, en este      fue la t&eacute;cnica quir&uacute;rgica m&aacute;s frecuentemente realizada,      ya sea en procederes donde se realiza solo la queratoplastia penetrante como      en otros procederes combinados con o sin implante de lente intraocular. </font></p >   <FONT size="+1">        <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">En conclusi&oacute;n,      consideramos que el conocimiento sobre el donante y el receptor para trasplante      de c&oacute;rnea es indispensable para garantizar el &eacute;xito en los resultados      finales del trasplante. El desarrollo de programas de trasplante y Bancos      de Ojos y el apoyo incondicional del Estado debe ser tarea prioritaria de      cada pa&iacute;s, pues de ellos depende que la discapacidad visual de causa      corneal pueda tener una soluci&oacute;n.     ]]></body>
<body><![CDATA[<br>         <br>     </font></p >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV > <FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   >        <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2"><B><font size="3">REFERENCIAS      BIBLIOGR&Aacute;FICA<FONT color="#000000"><B>S</b></font></font></b></font></p> </DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">     <DIV class="Part"   >     <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">1.          Epelde </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">Garralda          </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">          A,</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">          </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">      ]]></body>
<body><![CDATA[    Iturralde </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">O,</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>          <font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">          Compains </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">E,</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>          <font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">          Maison </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">C,</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>          <font face="Verdana, Arial, Helvetica, sans-serif" size="2"> </font><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">Altarriba          </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">M,          </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>          <font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">Goldaracena          MB, Marav&iacute;-Poma </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">E,      ]]></body>
<body><![CDATA[    et<font size="+1"> </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">al.      <!-- ref -->    Cornea transplant. An Sist Sanit Navar. 2010;29(Supl. 2):163-74.    </font></p> </DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>  <FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <!-- ref --><DIV class="Part"   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">2.    Pena JL, Redel I, Payahuela D. Trasplante de c&oacute;rnea: perfil epidemiol&oacute;gico    y resultados en 9 a&ntilde;os de experiencia. CIMEL. 2009;10(2):14-21.     </font></DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>      <!-- ref --><p><font size="2" face="Verdana, Arial, Helvetica, sans-serif" color="#000000">3.    Ocular Surgery News Europe Edition. Eye Banks worldwide increasing standards    expanding mission ocular surgery news Europe Edition. November 2012. <U><a href="http://www.healio.com/ophthalmology/cornea-externaldisease/news/print/ocular-surgery-news-europe-edition/%7B00d4ed9b-327f43a8-878d-8a57c0609e56%7D/eye-banks-worldwide-increasing-standardsexpanding-mission" target="_blank">http://www.healio.com/ophthalmology/cornea-externaldisease/news/print/ocular-surgery-news-europe-edition/%7B00d4ed9b-327f43a8-878d-8a57c0609e56%7D/eye-banks-worldwide-increasing-standardsexpanding-mission</a>    </U></font> <!-- ref --><DIV class="Part"   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">4. </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Galluzzi</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>    <font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Dos    Santos C, </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Mattos</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>    <font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Pacini    K, </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Bueno    </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>    <font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Ad&aacute;n    C, </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Hideo</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>    <font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Sato    E. Motivos do descarte de c&oacute;rneas captadas pelo banco de olhos do Hospital    S&atilde;o Paulo em dois anos. Rev Bras Oftalmol [Serial on the Internet]. 2010    [citado l8 de junio de 2014];69(1):18-22. Available from: <a href="http://www.scielo.br/scielo.php?script=sci_arttext&pid=S003472802010000100004&lng=en.%20http://dx.doi.org/10.1590/S003472802010000100004" target="_blank">http://www.scielo.br/scielo.php?script=sci_arttext&amp;pid=S003472802010000100004&amp;lng=en.    <U>http://dx.doi.org/10.1590/S003472802010000100004</U></a><U> </U></font></DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">     <DIV class="Part"   >    <br>   <FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">    </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   >        ]]></body>
<body><![CDATA[<p><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">5.          </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Ferreira          da</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>          <font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Silva          R, </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Urtiga          de</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>          <font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Vargas          N, </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Andrade</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>          <font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Rocha          G, </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Lopes</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>      ]]></body>
<body><![CDATA[    <font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Freitas          M, </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Barbosa</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>          <font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Souza          L, </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Pimentel</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>          <font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Moreno          N, et al . Avalia&ccedil;&atilde;o de tecido corneano processado por um Banco          de Olhos de refer&ecirc;ncia. Arq Bras Oftalmol [Internet]. 2009 [cited 2014          June 18];</font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">72(5):673-6.</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">          Available from: <a href="http://www.scielo.br/scielo.php?script=sci_arttext&pid=S000427492009000500015&lng=en.%20http://dx.doi.org/10.1590/S000427492009000500015" target="_blank">http://www.scielo.br/scielo.php?script=sci_arttext&amp;pid=S000427492009000500015&amp;lng=en.          <U>http://dx.doi.org/10.1590/S000427492009000500015</U></a><U> </U></font></p>     ]]></body>
<body><![CDATA[  <FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV     >     <!-- ref --></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   >        <!-- ref --><p><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">6.      Gogia V, Gupta S, Titiyal JS, Panda A, Pandey RM, Tandon R. A preliminary      descriptive analysis of Corneal Transplant Registry of National Eye Bank in      India. Contact lens and anterior eye. 2014 </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">[</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">cited      2014 June 13</font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">];37(2):111-5</font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">]</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>.      </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Available      from: <U><a href="http://linkinghub.elsevier.com/retrieve/pii/S1367048413002695?showall=true" target="_blank">http://linkinghub.elsevier.com/retrieve/pii/S1367048413002695?showall=true</a></U></font><DIV class="Part"   >        <!-- ref --><p><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">7.      Yuiti Sano R, Tiemi Sano F, Nishiwaki Dantas MC, Fioravanti Lui AC, Eimi Sano      M, Neto Adamo L. An&aacute;lise das c&oacute;rneas do Banco de Olhos da Santa      Casa de S&atilde;o Paulo utilizadas em transplantes. Arq Bras Oftalmol. 2010;73(3):254-8.          </font></p>   <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT color="#0000FF"><FONT color="#000000"><FONT color="#0000FF"><FONT color="#000000"><FONT color="#0000FF"><FONT color="#000000"><FONT color="#0000FF"><FONT color="#000000">    </font></font></font></font></font></font></font></font></font></font></font></DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   ><FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT color="#0000FF"><FONT color="#000000"><FONT color="#0000FF"><FONT color="#000000"><FONT color="#0000FF"><FONT color="#000000"><FONT color="#0000FF"><FONT color="#000000">       ]]></body>
<body><![CDATA[<!-- ref --><p   ><font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">8.<font color="#FF0000">      <font color="#000000">Eye Bank Association of America. About the EBAA. Medical      Standards. </font></font></font><font size="+1" color="#000000"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Washington:      EBAA</font></font> <font face="Verdana, Arial, Helvetica, sans-serif" size="2" color="#000000">[Internet].      2006 [cited 2008 Dec 5]. Available from: <U><a href="http://www.restoresight.org/aboutus" target="_blank">http://www.restoresight.org/aboutus</a>      </U></font></p >   </font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">    </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">     <DIV class="Part"   >        <!-- ref --><p><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">9.      Gleisson Rezende P, M&aacute;rcio Zapparolli G, Barroso Guedes WM, Dimartini      Junior C, Carvalho Vidal D, Wasilewski Hamilton M. Avalia&ccedil;&atilde;o      da qualidade das c&oacute;rneas doadoras em rela&ccedil;&atilde;o &agrave;      idade do doador e causa do &oacute;bito. Arq Bras Oftalmol. 2009;72(5):631-5.    </font></p> </DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">     <DIV class="Part"   >       <!-- ref --><p><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">10.      Belmonte J, Moral V. Idoneidad del injerto corneal de donante neonato en la      queratoplastia penetrante. Arch Soc Esp Oftalmol. 2008;83:219-30.     </font></p>   <FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">    </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   >        <!-- ref --><p><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">11.      Sugar A, Montoya MM, Beck R, Cowden JW, Dontchev M, Gal RL, Kollman C, Malling      J, Mannis MJ, Tennant B. Cornea Donor Study Investigator Group Impact of the      cornea donor study on acceptance of corneas from older donors. Am J Ophthalmol.      2009;147(3):432-8.     </font></p>   <FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">    </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      ]]></body>
<body><![CDATA[<DIV class="Part"   >        <!-- ref --><p><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">12.      Gal RL, Dontchev M, Beck RW, Mannis MJ, Holland EJ, Kollman C, et al. The      effect of donor age on corneal transplantation outcome results of the cornea      donor study. Cornea Donor Study Investigator Group. Ophthalmology. 2008;115(4):620-6.          </font></p>   <FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">    </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   >        <!-- ref --><p><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">13.      Gaum L, Reynolds I, Jones MNA. Tissue and corneal donation and transplantation      in the UK. British Journal of Anesthesia. 2012;108(Suppl. 1):43-7.     </font></p>   <FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">    </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   >        <!-- ref --><p><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">14.      L&oacute;pez Hern&aacute;ndez S, Moreno Ram&iacute;rez ME, Escalona Leyva      E. Keratoplasty: clinical characteristics and evaluation on results. Rev Cubana      Oftalmol. 2008;21(1):1-5.     </font></p>    </DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>     <DIV class="Part"   >        ]]></body>
<body><![CDATA[<!-- ref --><p><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">15.      Oficina Nacional de Estad&iacute;stica e Informaci&oacute;n de la Rep&uacute;blica      de Cuba. Anuario estad&iacute;stico de Cuba. 2011 [citado l8 de junio de 2014]      Disponible en: </font><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif"><a href="http://www.one.cu/aec2011/esp/19_tabla_cuadro.htm" target="_blank">http://<U>www.one.cu/aec2011/esp/19_tabla_cuadro</U>.htm</a></font><DIV class="Part"   >        <!-- ref --><p><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">16.      Escalona Leyva E, Jare&ntilde;o Ochoa M, L&oacute;pez Hern&aacute;ndez S,      Castillo P&eacute;rez A, P&eacute;rez Parra Z, Rodr&iacute;guez de Paz U.      Comportamiento de los trasplantes de c&oacute;rnea en el instituto Cubano      de Oftalmolog&iacute;a &quot;Ram&oacute;n Pando Ferrer&quot; (enero a Noviembre      2006). Rev Cubana Oftalmol. 2009;22(Supl. 1):47-51.     </font></p>   <FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">    </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   >        <!-- ref --><p><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">17.      Cunningham WJ, Brookes NH, Twohill HC, Moffatt SL, Pendergrast DG, Stewart      JM, McGhee CN. Trends in the distribution of donor corneal tissue and indications      for corneal transplantation: the New Zealand National Eye Bank Study 2000-2009.      Acta Ophthalmol. 2011;89(8):734-40.     </font></p>   <FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">    </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      <DIV class="Part"   >        <!-- ref --><p><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">18.      Tsiklis NS, Miltsakakis </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">DG</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">,      Georgiadis </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">NS</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">,      Georgiadou IN, Kymionis </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">      GD</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">,      Pallikaris </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">      IG</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font size="2" face="Verdana, Arial, Helvetica, sans-serif">.</font><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">      Changing indications for penetrating keratoplasty in Greece. Cornea. 2010;29(4):372-4.          </font></p>   <FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">    </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">      ]]></body>
<body><![CDATA[<DIV class="Part"   >        <p><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">19.          </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Ting</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>          <font face="Verdana, Arial, Helvetica, sans-serif" size="2">Darren SJ, </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">          Sau </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">Y</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">,          Srinivasan </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">S</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">,          Ramaesh</font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">          K</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">,          Mantry </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">S</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">,          Roberts </font><font size="+1" color="#000000"><font color="#212121"><font color="#000000"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="+1"><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">F</font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><font size="2" color="#000000" face="Verdana, Arial, Helvetica, sans-serif">.      ]]></body>
<body><![CDATA[    Changing trends in Keratoplasty in the west of Scotland: a 10 year review.      <!-- ref -->    Br J Ophthalmol. 2012;96(3):405-8.     </font></p> </DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>      <blockquote>        <p>&nbsp;</p>   <FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">        <DIV class="Part"   >          <p>&nbsp;</p>   </DIV >   </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font><FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">    </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></blockquote> <FONT size="+1" color="#000000"><FONT color="#212121"><FONT color="#000000"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1"><FONT size="+1">     <DIV class="Part"   >        <p><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Recibido:12 de      julio de 2014.    <br>     Aprobado: 20 de agosto de 2014.</font></p>       ]]></body>
<body><![CDATA[<p>&nbsp;</p>       <p>&nbsp;</p>   <FONT size="+1" color="#000000"><FONT size="+1"><FONT size="+1"><FONT color="#0000FF"><FONT color="#000000"><FONT color="#0000FF"><FONT color="#000000"><FONT color="#0000FF"><FONT color="#000000"><FONT color="#0000FF"><FONT color="#000000"><FONT color="#0000FF"><FONT color="#000000">        <p   align="justify" ><font face="Verdana, Arial, Helvetica, sans-serif" size="2">Dra. <I>Elizabeth      Teresa Escalona Leyva</I>. Instituto Cubano de Oftalmolog&iacute;a &quot;Ram&oacute;n      Pando Ferrer&quot;. Ave. 76 No. 3104 entre 31 y 41 Marianao, La Habana, Cuba.      Correo electr&oacute;nico: <U><FONT color="#0000FF"><a href="mailto:eliescal@infomed.sld.cu">eliescal@infomed.sld.cu</a>      </font></U></font></p >   </font></font></font></font></font></font></font></font></font></font></font></font></font></DIV > </font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font></font>       ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Epelde Garralda]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Iturralde]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Compains]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Maison]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Altarriba]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Goldaracena]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Maraví-Poma]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cornea transplant]]></article-title>
<source><![CDATA[An Sist Sanit Navar]]></source>
<year>2010</year>
<volume>29</volume>
<numero>^s2</numero>
<issue>^s2</issue>
<supplement>2</supplement>
<page-range>163-74</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pena]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Redel]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Payahuela]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Trasplante de córnea: perfil epidemiológico y resultados en 9 años de experiencia]]></article-title>
<source><![CDATA[CIMEL]]></source>
<year>2009</year>
<volume>10</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>14-21</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<source><![CDATA[Ocular Surgery News Europe Edition: Eye Banks worldwide increasing standards expanding mission ocular surgery news Europe Edition]]></source>
<year>Nove</year>
<month>mb</month>
<day>er</day>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Galluzzi Dos Santos]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Mattos Pacini]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Bueno Adán]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Hideo Sato]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Motivos do descarte de córneas captadas pelo banco de olhos do Hospital São Paulo em dois anos]]></article-title>
<source><![CDATA[Rev Bras Oftalmol]]></source>
<year>2010</year>
<volume>69</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>18-22</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferreira da Silva]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Urtiga de Vargas]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Andrade Rocha]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Lopes Freitas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Barbosa Souza]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Pimentel Moreno]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Avaliação de tecido corneano processado por um Banco de Olhos de referência]]></article-title>
<source><![CDATA[Arq Bras Oftalmol]]></source>
<year>2009</year>
<volume>72</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>673-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gogia]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Titiyal]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Panda]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pandey]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Tandon]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[A preliminary descriptive analysis of Corneal Transplant Registry of National Eye Bank in India]]></article-title>
<source><![CDATA[Contact lens and anterior eye]]></source>
<year>2014</year>
<volume>37</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>111-5</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yuiti Sano]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Tiemi Sano]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Nishiwaki Dantas]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Fioravanti Lui]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Eimi Sano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Neto Adamo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Análise das córneas do Banco de Olhos da Santa Casa de São Paulo utilizadas em transplantes]]></article-title>
<source><![CDATA[Arq Bras Oftalmol]]></source>
<year>2010</year>
<volume>73</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>254-8</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<collab>Eye Bank Association of America</collab>
<source><![CDATA[About the EBAA: Medical Standards]]></source>
<year>2006</year>
<publisher-loc><![CDATA[Washington ]]></publisher-loc>
<publisher-name><![CDATA[EBAA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gleisson Rezende]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Márcio Zapparolli]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Barroso Guedes]]></surname>
<given-names><![CDATA[WM]]></given-names>
</name>
<name>
<surname><![CDATA[Dimartini Junior]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho Vidal]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Wasilewski Hamilton]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="pt"><![CDATA[Avaliação da qualidade das córneas doadoras em relação à idade do doador e causa do óbito]]></article-title>
<source><![CDATA[Arq Bras Oftalmol]]></source>
<year>2009</year>
<volume>72</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>631-5</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Belmonte]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Moral]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Idoneidad del injerto corneal de donante neonato en la queratoplastia penetrante]]></article-title>
<source><![CDATA[Arch Soc Esp Oftalmol]]></source>
<year>2008</year>
<volume>83</volume>
<page-range>219-30</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sugar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Montoya]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Beck]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cowden]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
<name>
<surname><![CDATA[Dontchev]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gal]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Kollman]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Malling]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mannis]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Tennant]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cornea Donor Study Investigator Group Impact of the cornea donor study on acceptance of corneas from older donors]]></article-title>
<source><![CDATA[Am J Ophthalmol]]></source>
<year>2009</year>
<volume>147</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>432-8</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gal]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Dontchev]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Beck]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Mannis]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Holland]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kollman]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The effect of donor age on corneal transplantation outcome results of the cornea donor study: Cornea Donor Study Investigator Group]]></article-title>
<source><![CDATA[Ophthalmology]]></source>
<year>2008</year>
<volume>115</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>620-6</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gaum]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Reynolds]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[MNA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Tissue and corneal donation and transplantation in the UK]]></article-title>
<source><![CDATA[British Journal of Anesthesia]]></source>
<year>2012</year>
<volume>108</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>43-7</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López Hernández]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno Ramírez]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Escalona Leyva]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Keratoplasty: clinical characteristics and evaluation on results]]></article-title>
<source><![CDATA[Rev Cubana Oftalmol]]></source>
<year>2008</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-5</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="">
<collab>Oficina Nacional de Estadística e Información de la República de Cuba</collab>
<source><![CDATA[Anuario estadístico de Cuba]]></source>
<year>2011</year>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Escalona Leyva]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Jareño Ochoa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[López Hernández]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Castillo Pérez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez Parra]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez de Paz]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Comportamiento de los trasplantes de córnea en el instituto Cubano de Oftalmología "Ramón Pando Ferrer" (enero a Noviembre 2006)]]></article-title>
<source><![CDATA[Rev Cubana Oftalmol]]></source>
<year>2009</year>
<volume>22</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>47-51</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cunningham]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Brookes]]></surname>
<given-names><![CDATA[NH]]></given-names>
</name>
<name>
<surname><![CDATA[Twohill]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
<name>
<surname><![CDATA[Moffatt]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Pendergrast]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[Stewart]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[McGhee]]></surname>
<given-names><![CDATA[CN]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Trends in the distribution of donor corneal tissue and indications for corneal transplantation: the New Zealand National Eye Bank Study 2000-2009]]></article-title>
<source><![CDATA[Acta Ophthalmol]]></source>
<year>2011</year>
<volume>89</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>734-40</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tsiklis]]></surname>
<given-names><![CDATA[NS]]></given-names>
</name>
<name>
<surname><![CDATA[Miltsakakis]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[Georgiadis]]></surname>
<given-names><![CDATA[NS]]></given-names>
</name>
<name>
<surname><![CDATA[Georgiadou]]></surname>
<given-names><![CDATA[IN]]></given-names>
</name>
<name>
<surname><![CDATA[Kymionis]]></surname>
<given-names><![CDATA[GD]]></given-names>
</name>
<name>
<surname><![CDATA[Pallikaris]]></surname>
<given-names><![CDATA[IG]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Changing indications for penetrating keratoplasty in Greece]]></article-title>
<source><![CDATA[Cornea]]></source>
<year>2010</year>
<volume>29</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>372-4</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ting Darren]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Sau]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Srinivasan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ramaesh]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Mantry]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Changing trends in Keratoplasty in the west of Scotland: a 10 year review]]></article-title>
<source><![CDATA[Br J Ophthalmol]]></source>
<year>2012</year>
<volume>96</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>405-8</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
